Fierce Pharma Asia—Astellas' brief IRA fight; Otsuka's psychedelic buy; Takeda's court loss
Fierce Pharma
SEPTEMBER 8, 2023
Three Japanese pharma companies lead our news stories from Asia this week. And Takeda is ordered to pay AbbVie nearly $480 million because of a manufacturing hiccup. Astellas has abandoned its challenge against the Inflation Reduction Act. Astellas has abandoned its challenge against the Inflation Reduction Act.
Let's personalize your content